BRIEF-FDA approves first subcutaneous C1 Esterase Inhibitor
June 22, 2017 at 17:52 PM EDT
* FDA approves first subcutaneous C1 Esterase Inhibitor to treat rare genetic disease
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.